#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=2 .
1-1	0-1	2	quantity	new	coref	12-29
1-2	2-3	.	_	_	_	_

#Text=Follicular Ovarian Reserve and Its Regulation
2-1	4-14	Follicular	abstract|abstract[4]	new|new[4]	ana|coref|ana|coref	2-5[0_4]|10-21|2-5[0_4]|10-21
2-2	15-22	Ovarian	person|abstract[4]	new|new[4]	coref	3-6
2-3	23-30	Reserve	abstract[4]	new[4]	_	_
2-4	31-34	and	_	_	_	_
2-5	35-38	Its	abstract|abstract[6]	giv|new[6]	coref|coref	19-12[159_6]|19-12[159_6]
2-6	39-49	Regulation	abstract[6]	new[6]	_	_

#Text=In mammals , the follicular ovarian reserve , constituted by primordial follicles , is established early on in life then keeps declining regularly throughout the reproductive period .
3-1	50-52	In	_	_	_	_
3-2	53-60	mammals	animal	new	_	_
3-3	61-62	,	_	_	_	_
3-4	63-66	the	place[9]	new[9]	coref	19-15[161_9]
3-5	67-77	follicular	place[9]	new[9]	_	_
3-6	78-85	ovarian	person|place[9]	giv|new[9]	coref	19-16
3-7	86-93	reserve	place[9]	new[9]	_	_
3-8	94-95	,	_	_	_	_
3-9	96-107	constituted	_	_	_	_
3-10	108-110	by	_	_	_	_
3-11	111-121	primordial	object[10]	new[10]	coref	4-4[14_10]
3-12	122-131	follicles	object[10]	new[10]	_	_
3-13	132-133	,	_	_	_	_
3-14	134-136	is	_	_	_	_
3-15	137-148	established	_	_	_	_
3-16	149-154	early	_	_	_	_
3-17	155-157	on	_	_	_	_
3-18	158-160	in	_	_	_	_
3-19	161-165	life	abstract	new	coref	3-25[12_0]
3-20	166-170	then	_	_	_	_
3-21	171-176	keeps	_	_	_	_
3-22	177-186	declining	_	_	_	_
3-23	187-196	regularly	_	_	_	_
3-24	197-207	throughout	_	_	_	_
3-25	208-211	the	abstract[12]	giv[12]	coref	4-17[17_12]
3-26	212-224	reproductive	abstract[12]	giv[12]	_	_
3-27	225-231	period	abstract[12]	giv[12]	_	_
3-28	232-233	.	_	_	_	_

#Text=The pool of primordial follicles serves as a source of growing follicles and fertilizable eggs for the entire female reproductive life .
4-1	234-237	The	place[13]	new[13]	coref	20-9[165_13]
4-2	238-242	pool	place[13]	new[13]	_	_
4-3	243-245	of	place[13]	new[13]	_	_
4-4	246-256	primordial	place[13]|object[14]	new[13]|giv[14]	coref	4-12[15_14]
4-5	257-266	follicles	place[13]|object[14]	new[13]|giv[14]	_	_
4-6	267-273	serves	_	_	_	_
4-7	274-276	as	_	_	_	_
4-8	277-278	a	_	_	_	_
4-9	279-285	source	_	_	_	_
4-10	286-288	of	_	_	_	_
4-11	289-296	growing	_	_	_	_
4-12	297-306	follicles	object[15]	giv[15]	coref	6-6[23_15]
4-13	307-310	and	object[15]	giv[15]	_	_
4-14	311-323	fertilizable	object[15]|object[16]	giv[15]|new[16]	_	_
4-15	324-328	eggs	object[15]|object[16]	giv[15]|new[16]	_	_
4-16	329-332	for	object[15]|object[16]	giv[15]|new[16]	_	_
4-17	333-336	the	object[15]|object[16]|abstract[17]	giv[15]|new[16]|giv[17]	coref	9-6[44_17]
4-18	337-343	entire	object[15]|object[16]|abstract[17]	giv[15]|new[16]|giv[17]	_	_
4-19	344-350	female	object[15]|object[16]|abstract[17]	giv[15]|new[16]|giv[17]	_	_
4-20	351-363	reproductive	object[15]|object[16]|abstract[17]	giv[15]|new[16]|giv[17]	_	_
4-21	364-368	life	object[15]|object[16]|abstract[17]	giv[15]|new[16]|giv[17]	_	_
4-22	369-370	.	_	_	_	_

#Text=Actually , each primordial follicle can remain quiescent for years ; be activated and enter the growing process ; or undergo atresia directly from the dormant stage .
5-1	371-379	Actually	_	_	_	_
5-2	380-381	,	_	_	_	_
5-3	382-386	each	animal[18]	new[18]	coref	8-23[0_18]
5-4	387-397	primordial	animal[18]	new[18]	_	_
5-5	398-406	follicle	animal[18]	new[18]	_	_
5-6	407-410	can	_	_	_	_
5-7	411-417	remain	_	_	_	_
5-8	418-427	quiescent	_	_	_	_
5-9	428-431	for	_	_	_	_
5-10	432-437	years	_	_	_	_
5-11	438-439	;	_	_	_	_
5-12	440-442	be	_	_	_	_
5-13	443-452	activated	_	_	_	_
5-14	453-456	and	_	_	_	_
5-15	457-462	enter	_	_	_	_
5-16	463-466	the	event[19]	new[19]	coref	19-8[158_19]
5-17	467-474	growing	event[19]	new[19]	_	_
5-18	475-482	process	event[19]	new[19]	_	_
5-19	483-484	;	_	_	_	_
5-20	485-487	or	_	_	_	_
5-21	488-495	undergo	_	_	_	_
5-22	496-503	atresia	abstract	new	_	_
5-23	504-512	directly	_	_	_	_
5-24	513-517	from	_	_	_	_
5-25	518-521	the	abstract[21]	new[21]	coref	7-2[26_21]
5-26	522-529	dormant	abstract[21]	new[21]	_	_
5-27	530-535	stage	abstract[21]	new[21]	_	_
5-28	536-537	.	_	_	_	_

#Text=To produce mature oocytes , activated primordial follicles develop through primary and secondary stages before acquiring an antral cavity .
6-1	538-540	To	_	_	_	_
6-2	541-548	produce	_	_	_	_
6-3	549-555	mature	object[22]	new[22]	coref	11-19[63_22]
6-4	556-563	oocytes	object[22]	new[22]	_	_
6-5	564-565	,	_	_	_	_
6-6	566-575	activated	object[23]	giv[23]	coref	7-6[27_23]
6-7	576-586	primordial	object[23]	giv[23]	_	_
6-8	587-596	follicles	object[23]	giv[23]	_	_
6-9	597-604	develop	_	_	_	_
6-10	605-612	through	_	_	_	_
6-11	613-620	primary	abstract[24]	new[24]	_	_
6-12	621-624	and	abstract[24]	new[24]	_	_
6-13	625-634	secondary	abstract[24]	new[24]	_	_
6-14	635-641	stages	abstract[24]	new[24]	_	_
6-15	642-648	before	_	_	_	_
6-16	649-658	acquiring	_	_	_	_
6-17	659-661	an	place[25]	new[25]	_	_
6-18	662-668	antral	place[25]	new[25]	_	_
6-19	669-675	cavity	place[25]	new[25]	_	_
6-20	676-677	.	_	_	_	_

#Text=At the antral stage , most follicles undergo apoptotic degeneration and only a few of them grow further to reach the preovulatory stage under the cyclic gonadotropin stimulation that occurs after puberty .
7-1	678-680	At	_	_	_	_
7-2	681-684	the	abstract[26]	giv[26]	coref	7-21[30_26]
7-3	685-691	antral	abstract[26]	giv[26]	_	_
7-4	692-697	stage	abstract[26]	giv[26]	_	_
7-5	698-699	,	_	_	_	_
7-6	700-704	most	object[27]	giv[27]	ana	7-16[0_27]
7-7	705-714	follicles	object[27]	giv[27]	_	_
7-8	715-722	undergo	_	_	_	_
7-9	723-732	apoptotic	abstract[28]	new[28]	_	_
7-10	733-745	degeneration	abstract[28]	new[28]	_	_
7-11	746-749	and	_	_	_	_
7-12	750-754	only	_	_	_	_
7-13	755-756	a	_	_	_	_
7-14	757-760	few	_	_	_	_
7-15	761-763	of	_	_	_	_
7-16	764-768	them	object	giv	coref	8-15[38_0]
7-17	769-773	grow	_	_	_	_
7-18	774-781	further	_	_	_	_
7-19	782-784	to	_	_	_	_
7-20	785-790	reach	_	_	_	_
7-21	791-794	the	abstract[30]	giv[30]	_	_
7-22	795-807	preovulatory	abstract[30]	giv[30]	_	_
7-23	808-813	stage	abstract[30]	giv[30]	_	_
7-24	814-819	under	_	_	_	_
7-25	820-823	the	abstract[32]	new[32]	_	_
7-26	824-830	cyclic	abstract[32]	new[32]	_	_
7-27	831-843	gonadotropin	person|abstract[32]	new|new[32]	_	_
7-28	844-855	stimulation	abstract[32]	new[32]	_	_
7-29	856-860	that	_	_	_	_
7-30	861-867	occurs	_	_	_	_
7-31	868-873	after	_	_	_	_
7-32	874-881	puberty	event	new	_	_
7-33	882-883	.	_	_	_	_

#Text=The maintenance of female reproductive function implies the presence of a vast majority of quiescent primordial follicles and continuous repression of primordial follicle activation into early growing follicles .
8-1	884-887	The	abstract[34]	new[34]	_	_
8-2	888-899	maintenance	abstract[34]	new[34]	_	_
8-3	900-902	of	abstract[34]	new[34]	_	_
8-4	903-909	female	abstract[34]|abstract[35]	new[34]|new[35]	_	_
8-5	910-922	reproductive	abstract[34]|abstract[35]	new[34]|new[35]	_	_
8-6	923-931	function	abstract[34]|abstract[35]	new[34]|new[35]	_	_
8-7	932-939	implies	_	_	_	_
8-8	940-943	the	abstract[36]	new[36]	_	_
8-9	944-952	presence	abstract[36]	new[36]	_	_
8-10	953-955	of	abstract[36]	new[36]	_	_
8-11	956-957	a	abstract[36]|abstract[37]	new[36]|new[37]	_	_
8-12	958-962	vast	abstract[36]|abstract[37]	new[36]|new[37]	_	_
8-13	963-971	majority	abstract[36]|abstract[37]	new[36]|new[37]	_	_
8-14	972-974	of	abstract[36]|abstract[37]	new[36]|new[37]	_	_
8-15	975-984	quiescent	abstract[36]|abstract[37]|object[38]	new[36]|new[37]|giv[38]	coref	12-4[68_38]
8-16	985-995	primordial	abstract[36]|abstract[37]|object[38]	new[36]|new[37]|giv[38]	_	_
8-17	996-1005	follicles	abstract[36]|abstract[37]|object[38]	new[36]|new[37]|giv[38]	_	_
8-18	1006-1009	and	abstract[36]|abstract[37]|object[38]	new[36]|new[37]|giv[38]	_	_
8-19	1010-1020	continuous	abstract[36]|abstract[37]|object[38]|event[39]	new[36]|new[37]|giv[38]|new[39]	_	_
8-20	1021-1031	repression	abstract[36]|abstract[37]|object[38]|event[39]	new[36]|new[37]|giv[38]|new[39]	_	_
8-21	1032-1034	of	abstract[36]|abstract[37]|object[38]|event[39]	new[36]|new[37]|giv[38]|new[39]	_	_
8-22	1035-1045	primordial	abstract[36]|abstract[37]|object[38]|event[39]|event[41]	new[36]|new[37]|giv[38]|new[39]|new[41]	coref	9-1[42_41]
8-23	1046-1054	follicle	abstract[36]|abstract[37]|object[38]|event[39]|animal|event[41]	new[36]|new[37]|giv[38]|new[39]|giv|new[41]	coref	15-31
8-24	1055-1065	activation	abstract[36]|abstract[37]|object[38]|event[39]|event[41]	new[36]|new[37]|giv[38]|new[39]|new[41]	_	_
8-25	1066-1070	into	abstract[36]|abstract[37]|object[38]|event[39]|event[41]	new[36]|new[37]|giv[38]|new[39]|new[41]	_	_
8-26	1071-1076	early	abstract[36]|abstract[37]|object[38]|event[39]|event[41]	new[36]|new[37]|giv[38]|new[39]|new[41]	_	_
8-27	1077-1084	growing	abstract[36]|abstract[37]|object[38]|event[39]|event[41]	new[36]|new[37]|giv[38]|new[39]|new[41]	_	_
8-28	1085-1094	follicles	abstract[36]|abstract[37]|object[38]|event[39]|event[41]	new[36]|new[37]|giv[38]|new[39]|new[41]	_	_
8-29	1095-1096	.	_	_	_	_

#Text=This activation , starting during fetal life , is finely controlled though maintaining a balance between inhibitory and stimulatory factors .
9-1	1097-1101	This	event[42]	giv[42]	coref	10-21[58_42]
9-2	1102-1112	activation	event[42]	giv[42]	_	_
9-3	1113-1114	,	_	_	_	_
9-4	1115-1123	starting	_	_	_	_
9-5	1124-1130	during	_	_	_	_
9-6	1131-1136	fetal	substance|time[44]	new|giv[44]	coref|coref	18-2[149_44]|18-2[149_44]
9-7	1137-1141	life	time[44]	giv[44]	_	_
9-8	1142-1143	,	_	_	_	_
9-9	1144-1146	is	_	_	_	_
9-10	1147-1153	finely	_	_	_	_
9-11	1154-1164	controlled	_	_	_	_
9-12	1165-1171	though	_	_	_	_
9-13	1172-1183	maintaining	_	_	_	_
9-14	1184-1185	a	abstract[45]	new[45]	coref	21-13[180_45]
9-15	1186-1193	balance	abstract[45]	new[45]	_	_
9-16	1194-1201	between	abstract[45]	new[45]	_	_
9-17	1202-1212	inhibitory	abstract[45]|abstract|abstract[47]|abstract[49]	new[45]|new|new[47]|new[49]	coref|coref|coref|coref|coref|coref|coref|coref|coref	11-1[59_49]|23-14[195_0]|23-14[196_47]|11-1[59_49]|23-14[195_0]|23-14[196_47]|11-1[59_49]|23-14[195_0]|23-14[196_47]
9-18	1213-1216	and	abstract[45]|abstract[47]|abstract[49]	new[45]|new[47]|new[49]	_	_
9-19	1217-1228	stimulatory	abstract[45]|abstract[47]|abstract|abstract[49]	new[45]|new[47]|new|new[49]	_	_
9-20	1229-1236	factors	abstract[45]|abstract[49]	new[45]|new[49]	_	_
9-21	1237-1238	.	_	_	_	_

#Text=In vitro experiments and genetically modified mouse or sheep models have enabled the decoding of the molecular mechanisms that control follicular activation .
10-1	1239-1241	In	_	_	_	_
10-2	1242-1247	vitro	organization|event[51]	new|new[51]	_	_
10-3	1248-1259	experiments	event[51]	new[51]	_	_
10-4	1260-1263	and	_	_	_	_
10-5	1264-1275	genetically	animal[52]	new[52]	coref	14-6[0_52]
10-6	1276-1284	modified	animal[52]	new[52]	_	_
10-7	1285-1290	mouse	animal[52]	new[52]	_	_
10-8	1291-1293	or	_	_	_	_
10-9	1294-1299	sheep	animal|abstract[54]	new|new[54]	coref|coref	14-4[101_54]|14-4[101_54]
10-10	1300-1306	models	abstract[54]	new[54]	_	_
10-11	1307-1311	have	_	_	_	_
10-12	1312-1319	enabled	_	_	_	_
10-13	1320-1323	the	abstract[55]	new[55]	_	_
10-14	1324-1332	decoding	abstract[55]	new[55]	_	_
10-15	1333-1335	of	abstract[55]	new[55]	_	_
10-16	1336-1339	the	abstract[55]|abstract[56]	new[55]|new[56]	coref	18-14[152_56]
10-17	1340-1349	molecular	abstract[55]|abstract[56]	new[55]|new[56]	_	_
10-18	1350-1360	mechanisms	abstract[55]|abstract[56]	new[55]|new[56]	_	_
10-19	1361-1365	that	_	_	_	_
10-20	1366-1373	control	abstract	new	coref|none	14-30[109_0]|10-20[0_109]
10-21	1374-1384	follicular	abstract|event[58]	giv|giv[58]	coref|coref|coref|coref	13-20[99_58]|15-36|13-20[99_58]|15-36
10-22	1385-1395	activation	event[58]	giv[58]	_	_
10-23	1396-1397	.	_	_	_	_

#Text=Numerous factors , such as growth factors , hormones , transcription factors , or cytokines , produced by oocytes and/or granulosa cells , can act in an autocrine , paracrine , or endocrine manner .
11-1	1398-1406	Numerous	abstract[59]	giv[59]	coref	21-24[184_59]
11-2	1407-1414	factors	abstract[59]	giv[59]	_	_
11-3	1415-1416	,	abstract[59]	giv[59]	_	_
11-4	1417-1421	such	abstract[59]	giv[59]	_	_
11-5	1422-1424	as	abstract[59]	giv[59]	_	_
11-6	1425-1431	growth	abstract[59]|abstract	giv[59]|new	_	_
11-7	1432-1439	factors	abstract[59]	giv[59]	_	_
11-8	1440-1441	,	abstract[59]	giv[59]	_	_
11-9	1442-1450	hormones	abstract[59]|substance	giv[59]|new	_	_
11-10	1451-1452	,	abstract[59]	giv[59]	_	_
11-11	1453-1466	transcription	abstract[59]	giv[59]	_	_
11-12	1467-1474	factors	abstract[59]	giv[59]	_	_
11-13	1475-1476	,	abstract[59]	giv[59]	_	_
11-14	1477-1479	or	abstract[59]	giv[59]	_	_
11-15	1480-1489	cytokines	abstract[59]|abstract	giv[59]|new	_	_
11-16	1490-1491	,	_	_	_	_
11-17	1492-1500	produced	_	_	_	_
11-18	1501-1503	by	_	_	_	_
11-19	1504-1511	oocytes	object[63]	giv[63]	coref	13-17[0_63]
11-20	1512-1518	and/or	object[63]	giv[63]	_	_
11-21	1519-1528	granulosa	object[63]|object[64]	giv[63]|new[64]	_	_
11-22	1529-1534	cells	object[63]|object[64]	giv[63]|new[64]	_	_
11-23	1535-1536	,	_	_	_	_
11-24	1537-1540	can	_	_	_	_
11-25	1541-1544	act	_	_	_	_
11-26	1545-1547	in	_	_	_	_
11-27	1548-1550	an	abstract[65]	new[65]	_	_
11-28	1551-1560	autocrine	abstract[65]	new[65]	_	_
11-29	1561-1562	,	_	_	_	_
11-30	1563-1572	paracrine	_	_	_	_
11-31	1573-1574	,	_	_	_	_
11-32	1575-1577	or	_	_	_	_
11-33	1578-1587	endocrine	abstract[66]	new[66]	coref	21-2[174_66]
11-34	1588-1594	manner	abstract[66]	new[66]	_	_
11-35	1595-1596	.	_	_	_	_

#Text=The quiescence of primordial follicles is maintained by several molecules including phosphatase and tensin homolog deleted on chromosome 10 ( Pten ) , tuberous sclerosis complexes 1 – 2 ( Tsc1 – Tsc2 ) complex , Forkhead box protein O3A ( Foxo3A ) , p27 , anti-Müllerian hormone ( AMH ) , and Forkhead box L2 ( FoxL2 ) .
12-1	1597-1600	The	abstract[67]	new[67]	_	_
12-2	1601-1611	quiescence	abstract[67]	new[67]	_	_
12-3	1612-1614	of	abstract[67]	new[67]	_	_
12-4	1615-1625	primordial	abstract[67]|object[68]	new[67]|giv[68]	coref	14-37[113_68]
12-5	1626-1635	follicles	abstract[67]|object[68]	new[67]|giv[68]	_	_
12-6	1636-1638	is	_	_	_	_
12-7	1639-1649	maintained	_	_	_	_
12-8	1650-1652	by	_	_	_	_
12-9	1653-1660	several	substance[69]	new[69]	coref	23-17[197_69]
12-10	1661-1670	molecules	substance[69]	new[69]	_	_
12-11	1671-1680	including	substance[69]	new[69]	_	_
12-12	1681-1692	phosphatase	substance[69]|substance	new[69]|new	_	_
12-13	1693-1696	and	substance[69]	new[69]	_	_
12-14	1697-1703	tensin	substance[69]|person|object[72]	new[69]|new|new[72]	_	_
12-15	1704-1711	homolog	substance[69]|object[72]	new[69]|new[72]	_	_
12-16	1712-1719	deleted	_	_	_	_
12-17	1720-1722	on	_	_	_	_
12-18	1723-1733	chromosome	place[73]	new[73]	_	_
12-19	1734-1736	10	place[73]	new[73]	_	_
12-20	1737-1738	(	place[73]	new[73]	_	_
12-21	1739-1743	Pten	place[73]|animal	new[73]|new	coref	15-4
12-22	1744-1745	)	place[73]	new[73]	_	_
12-23	1746-1747	,	_	_	_	_
12-24	1748-1756	tuberous	abstract[76]	new[76]	appos	12-31[78_76]
12-25	1757-1766	sclerosis	place|abstract[76]	new|new[76]	_	_
12-26	1767-1776	complexes	abstract[76]	new[76]	_	_
12-27	1777-1778	1	abstract[76]	new[76]	_	_
12-28	1779-1780	–	abstract[76]	new[76]	_	_
12-29	1781-1782	2	abstract[76]|quantity	new[76]|giv	coref	15-8
12-30	1783-1784	(	_	_	_	_
12-31	1785-1789	Tsc1	abstract[78]	giv[78]	_	_
12-32	1790-1791	–	abstract[78]	giv[78]	_	_
12-33	1792-1796	Tsc2	abstract[78]|abstract	giv[78]|new	_	_
12-34	1797-1798	)	_	_	_	_
12-35	1799-1806	complex	_	_	_	_
12-36	1807-1808	,	_	_	_	_
12-37	1809-1817	Forkhead	object|object[83]	new|new[83]	appos|coref|appos|coref	12-42[0_83]|12-54|12-42[0_83]|12-54
12-38	1818-1821	box	object|object[83]	new|new[83]	coref	12-55
12-39	1822-1829	protein	substance|object[83]	new|new[83]	coref	22-14[190_0]
12-40	1830-1833	O3A	object[83]	new[83]	_	_
12-41	1834-1835	(	_	_	_	_
12-42	1836-1842	Foxo3A	object	giv	_	_
12-43	1843-1844	)	_	_	_	_
12-44	1845-1846	,	_	_	_	_
12-45	1847-1850	p27	abstract	new	_	_
12-46	1851-1852	,	_	_	_	_
12-47	1853-1867	anti-Müllerian	person|substance[87]	new|new[87]	_	_
12-48	1868-1875	hormone	substance[87]	new[87]	_	_
12-49	1876-1877	(	_	_	_	_
12-50	1878-1881	AMH	object	new	_	_
12-51	1882-1883	)	_	_	_	_
12-52	1884-1885	,	_	_	_	_
12-53	1886-1889	and	_	_	_	_
12-54	1890-1898	Forkhead	object|abstract[91]	giv|new[91]	_	_
12-55	1899-1902	box	object|abstract[91]	giv|new[91]	_	_
12-56	1903-1905	L2	abstract[91]	new[91]	_	_
12-57	1906-1907	(	_	_	_	_
12-58	1908-1913	FoxL2	abstract	new	_	_
12-59	1914-1915	)	_	_	_	_
12-60	1916-1917	.	_	_	_	_

#Text=Many studies have highlighted the crucial roles of the phosphatidyl-inositol-3-kinase ( PI3K ) signaling pathway in oocytes in controlling follicular activation .
13-1	1918-1922	Many	abstract[93]	new[93]	coref	19-1[155_93]
13-2	1923-1930	studies	abstract[93]	new[93]	_	_
13-3	1931-1935	have	_	_	_	_
13-4	1936-1947	highlighted	_	_	_	_
13-5	1948-1951	the	abstract[94]	new[94]	_	_
13-6	1952-1959	crucial	abstract[94]	new[94]	_	_
13-7	1960-1965	roles	abstract[94]	new[94]	_	_
13-8	1966-1968	of	abstract[94]	new[94]	_	_
13-9	1969-1972	the	abstract[94]|abstract[95]	new[94]|new[95]	appos	13-12[0_95]
13-10	1973-2003	phosphatidyl-inositol-3-kinase	abstract[94]|abstract[95]	new[94]|new[95]	_	_
13-11	2004-2005	(	abstract[94]	new[94]	_	_
13-12	2006-2010	PI3K	abstract[94]|abstract	new[94]|giv	ana	14-9
13-13	2011-2012	)	abstract[94]	new[94]	_	_
13-14	2013-2022	signaling	abstract[94]|place[97]	new[94]|new[97]	coref	14-26[0_97]
13-15	2023-2030	pathway	abstract[94]|place[97]	new[94]|new[97]	_	_
13-16	2031-2033	in	abstract[94]|place[97]	new[94]|new[97]	_	_
13-17	2034-2041	oocytes	abstract[94]|place[97]|object	new[94]|new[97]|giv	coref	15-27
13-18	2042-2044	in	_	_	_	_
13-19	2045-2056	controlling	_	_	_	_
13-20	2057-2067	follicular	event[99]	giv[99]	coref	14-35[112_99]
13-21	2068-2078	activation	event[99]	giv[99]	_	_
13-22	2079-2080	.	_	_	_	_

#Text=Indeed , in genetically modified mouse models , it was observed that the PI3K – Akt – mammalian target of rapamycin ( mTOR ) signaling pathway is crucial for the control of survival and activation of primordial follicles .
14-1	2081-2087	Indeed	_	_	_	_
14-2	2088-2089	,	_	_	_	_
14-3	2090-2092	in	_	_	_	_
14-4	2093-2104	genetically	abstract[101]	giv[101]	coref	16-2[128_101]
14-5	2105-2113	modified	abstract[101]	giv[101]	_	_
14-6	2114-2119	mouse	animal|abstract[101]	giv|giv[101]	_	_
14-7	2120-2126	models	abstract[101]	giv[101]	_	_
14-8	2127-2128	,	_	_	_	_
14-9	2129-2131	it	abstract	giv	coref	14-13[103_0]
14-10	2132-2135	was	_	_	_	_
14-11	2136-2144	observed	_	_	_	_
14-12	2145-2149	that	_	_	_	_
14-13	2150-2153	the	abstract[103]	giv[103]	appos	14-16[0_103]
14-14	2154-2158	PI3K	abstract[103]	giv[103]	_	_
14-15	2159-2160	–	_	_	_	_
14-16	2161-2164	Akt	abstract	giv	coref	17-19
14-17	2165-2166	–	_	_	_	_
14-18	2167-2176	mammalian	abstract[105]	new[105]	_	_
14-19	2177-2183	target	abstract[105]	new[105]	_	_
14-20	2184-2186	of	abstract[105]	new[105]	_	_
14-21	2187-2196	rapamycin	abstract[105]|abstract	new[105]|new	appos	14-23
14-22	2197-2198	(	_	_	_	_
14-23	2199-2203	mTOR	abstract	giv	coref	16-5
14-24	2204-2205	)	_	_	_	_
14-25	2206-2215	signaling	_	_	_	_
14-26	2216-2223	pathway	place	giv	coref	15-13[119_0]
14-27	2224-2226	is	_	_	_	_
14-28	2227-2234	crucial	_	_	_	_
14-29	2235-2238	for	_	_	_	_
14-30	2239-2242	the	abstract[109]	new[109]	_	_
14-31	2243-2250	control	abstract[109]	new[109]	_	_
14-32	2251-2253	of	abstract[109]	new[109]	_	_
14-33	2254-2262	survival	abstract[109]|event|event[111]	new[109]|new|new[111]	coref|coref	21-2[177_111]|21-2[177_111]
14-34	2263-2266	and	abstract[109]|event[111]	new[109]|new[111]	_	_
14-35	2267-2277	activation	abstract[109]|event[111]|event[112]	new[109]|new[111]|giv[112]	coref	15-30[125_112]
14-36	2278-2280	of	abstract[109]|event[111]|event[112]	new[109]|new[111]|giv[112]	_	_
14-37	2281-2291	primordial	abstract[109]|event[111]|event[112]|object[113]	new[109]|new[111]|giv[112]|giv[113]	coref	17-13[0_113]
14-38	2292-2301	follicles	abstract[109]|event[111]|event[112]|object[113]	new[109]|new[111]|giv[112]|giv[113]	_	_
14-39	2302-2303	.	_	_	_	_

#Text=For example , Pten and Tsc1 – 2 are negative regulators of this signaling pathway and , in mice , the deletion of these genes from oocytes leads to primordial follicle activation and subsequent early follicular depletion .
15-1	2304-2307	For	_	_	_	_
15-2	2308-2315	example	_	_	_	_
15-3	2316-2317	,	_	_	_	_
15-4	2318-2322	Pten	abstract	giv	_	_
15-5	2323-2326	and	_	_	_	_
15-6	2327-2331	Tsc1	abstract[115]	new[115]	coref	15-10[117_115]
15-7	2332-2333	–	abstract[115]	new[115]	_	_
15-8	2334-2335	2	abstract[115]|quantity	new[115]|giv	_	_
15-9	2336-2339	are	_	_	_	_
15-10	2340-2348	negative	abstract[117]	giv[117]	_	_
15-11	2349-2359	regulators	abstract[117]	giv[117]	_	_
15-12	2360-2362	of	abstract[117]	giv[117]	_	_
15-13	2363-2367	this	abstract[117]|place[119]	giv[117]|giv[119]	coref	17-18[146_119]
15-14	2368-2377	signaling	abstract[117]|abstract|place[119]	giv[117]|new|giv[119]	coref	17-20
15-15	2378-2385	pathway	abstract[117]|place[119]	giv[117]|giv[119]	_	_
15-16	2386-2389	and	_	_	_	_
15-17	2390-2391	,	_	_	_	_
15-18	2392-2394	in	_	_	_	_
15-19	2395-2399	mice	animal	new	_	_
15-20	2400-2401	,	_	_	_	_
15-21	2402-2405	the	event[121]	new[121]	_	_
15-22	2406-2414	deletion	event[121]	new[121]	_	_
15-23	2415-2417	of	event[121]	new[121]	_	_
15-24	2418-2423	these	event[121]|abstract[122]	new[121]|new[122]	_	_
15-25	2424-2429	genes	event[121]|abstract[122]	new[121]|new[122]	_	_
15-26	2430-2434	from	event[121]|abstract[122]	new[121]|new[122]	_	_
15-27	2435-2442	oocytes	event[121]|abstract[122]|object	new[121]|new[122]|giv	coref	17-9[140_0]
15-28	2443-2448	leads	_	_	_	_
15-29	2449-2451	to	_	_	_	_
15-30	2452-2462	primordial	event[125]	giv[125]	coref	16-22[136_125]
15-31	2463-2471	follicle	animal|event[125]	giv|giv[125]	coref	16-23
15-32	2472-2482	activation	event[125]	giv[125]	_	_
15-33	2483-2486	and	_	_	_	_
15-34	2487-2497	subsequent	event[127]	new[127]	_	_
15-35	2498-2503	early	event[127]	new[127]	_	_
15-36	2504-2514	follicular	abstract|event[127]	giv|new[127]	coref	23-26
15-37	2515-2524	depletion	event[127]	new[127]	_	_
15-38	2525-2526	.	_	_	_	_

#Text=In these models , mTOR activity is accelerated within the oocyte , highlighting the critical role of this serine/threonine kinase in primordial follicle activation .
16-1	2527-2529	In	_	_	_	_
16-2	2530-2535	these	abstract[128]	giv[128]	_	_
16-3	2536-2542	models	abstract[128]	giv[128]	_	_
16-4	2543-2544	,	_	_	_	_
16-5	2545-2549	mTOR	place|abstract[130]	giv|new[130]	_	_
16-6	2550-2558	activity	abstract[130]	new[130]	_	_
16-7	2559-2561	is	_	_	_	_
16-8	2562-2573	accelerated	_	_	_	_
16-9	2574-2580	within	_	_	_	_
16-10	2581-2584	the	object[131]	new[131]	coref	20-11[0_131]
16-11	2585-2591	oocyte	object[131]	new[131]	_	_
16-12	2592-2593	,	_	_	_	_
16-13	2594-2606	highlighting	_	_	_	_
16-14	2607-2610	the	abstract[132]	new[132]	coref	10-20[0_132]
16-15	2611-2619	critical	abstract[132]	new[132]	_	_
16-16	2620-2624	role	abstract[132]	new[132]	_	_
16-17	2625-2627	of	abstract[132]	new[132]	_	_
16-18	2628-2632	this	abstract[132]|abstract[134]	new[132]|new[134]	_	_
16-19	2633-2649	serine/threonine	abstract[132]|substance|abstract[134]	new[132]|new|new[134]	_	_
16-20	2650-2656	kinase	abstract[132]|abstract[134]	new[132]|new[134]	_	_
16-21	2657-2659	in	abstract[132]|abstract[134]	new[132]|new[134]	_	_
16-22	2660-2670	primordial	abstract[132]|abstract[134]|event[136]	new[132]|new[134]|giv[136]	coref	17-31[148_136]
16-23	2671-2679	follicle	abstract[132]|abstract[134]|animal|event[136]	new[132]|new[134]|giv|giv[136]	coref	21-7
16-24	2680-2690	activation	abstract[132]|abstract[134]|event[136]	new[132]|new[134]|giv[136]	_	_
16-25	2691-2692	.	_	_	_	_

#Text=The transcription factor FoxO3A , mainly expressed in the oocytes of resting follicles , acts downstream of the PI3K signaling pathway and appears to be the main actor involved in follicular activation .
17-1	2693-2696	The	abstract[138]|abstract[139]	new[138]|new[139]	_	_
17-2	2697-2710	transcription	abstract|abstract[138]|abstract[139]	new|new[138]|new[139]	_	_
17-3	2711-2717	factor	abstract[138]|abstract[139]	new[138]|new[139]	_	_
17-4	2718-2724	FoxO3A	abstract[139]	new[139]	_	_
17-5	2725-2726	,	_	_	_	_
17-6	2727-2733	mainly	_	_	_	_
17-7	2734-2743	expressed	_	_	_	_
17-8	2744-2746	in	_	_	_	_
17-9	2747-2750	the	object[140]	giv[140]	_	_
17-10	2751-2758	oocytes	object[140]	giv[140]	_	_
17-11	2759-2761	of	_	_	_	_
17-12	2762-2769	resting	_	_	_	_
17-13	2770-2779	follicles	object	giv	coref	18-9[151_0]
17-14	2780-2781	,	_	_	_	_
17-15	2782-2786	acts	abstract|place[143]	new|new[143]	_	_
17-16	2787-2797	downstream	place[143]	new[143]	_	_
17-17	2798-2800	of	place[143]	new[143]	_	_
17-18	2801-2804	the	place[143]|place[146]	new[143]|giv[146]	_	_
17-19	2805-2809	PI3K	place[143]|abstract|place[146]	new[143]|giv|giv[146]	_	_
17-20	2810-2819	signaling	place[143]|abstract|place[146]	new[143]|giv|giv[146]	coref	18-17[154_0]
17-21	2820-2827	pathway	place[143]|place[146]	new[143]|giv[146]	_	_
17-22	2828-2831	and	_	_	_	_
17-23	2832-2839	appears	_	_	_	_
17-24	2840-2842	to	_	_	_	_
17-25	2843-2845	be	_	_	_	_
17-26	2846-2849	the	abstract[147]	new[147]	_	_
17-27	2850-2854	main	abstract[147]	new[147]	_	_
17-28	2855-2860	actor	abstract[147]	new[147]	_	_
17-29	2861-2869	involved	_	_	_	_
17-30	2870-2872	in	_	_	_	_
17-31	2873-2883	follicular	event[148]	giv[148]	coref	23-9[194_148]
17-32	2884-2894	activation	event[148]	giv[148]	_	_
17-33	2895-2896	.	_	_	_	_

#Text=At the same time , the survival of primordial follicles is maintained by other mechanisms involving PDK1 signaling , rpS6 .
18-1	2897-2899	At	_	_	_	_
18-2	2900-2903	the	time[149]	giv[149]	_	_
18-3	2904-2908	same	time[149]	giv[149]	_	_
18-4	2909-2913	time	time[149]	giv[149]	_	_
18-5	2914-2915	,	_	_	_	_
18-6	2916-2919	the	event[150]	new[150]	coref	21-2[176_150]
18-7	2920-2928	survival	event[150]	new[150]	_	_
18-8	2929-2931	of	event[150]	new[150]	_	_
18-9	2932-2942	primordial	event[150]|object[151]	new[150]|giv[151]	coref	19-19[162_151]
18-10	2943-2952	follicles	event[150]|object[151]	new[150]|giv[151]	_	_
18-11	2953-2955	is	_	_	_	_
18-12	2956-2966	maintained	_	_	_	_
18-13	2967-2969	by	_	_	_	_
18-14	2970-2975	other	abstract[152]	giv[152]	coref	24-4[204_152]
18-15	2976-2986	mechanisms	abstract[152]	giv[152]	_	_
18-16	2987-2996	involving	abstract[152]	giv[152]	_	_
18-17	2997-3001	PDK1	abstract[152]|abstract|abstract[154]	giv[152]|new|giv[154]	_	_
18-18	3002-3011	signaling	abstract[152]|abstract[154]	giv[152]|giv[154]	_	_
18-19	3012-3013	,	abstract[152]|abstract[154]	giv[152]|giv[154]	_	_
18-20	3014-3018	rpS6	abstract[152]|abstract[154]	giv[152]|giv[154]	_	_
18-21	3019-3020	.	_	_	_	_

#Text=Several studies have suggested the involvement of the autophagy process in the regulation of the ovarian reserve of primordial follicles .
19-1	3021-3028	Several	abstract[155]	giv[155]	_	_
19-2	3029-3036	studies	abstract[155]	giv[155]	_	_
19-3	3037-3041	have	_	_	_	_
19-4	3042-3051	suggested	_	_	_	_
19-5	3052-3055	the	abstract[156]	new[156]	_	_
19-6	3056-3067	involvement	abstract[156]	new[156]	_	_
19-7	3068-3070	of	abstract[156]	new[156]	_	_
19-8	3071-3074	the	abstract[156]|event[158]	new[156]|giv[158]	coref	23-31[201_158]
19-9	3075-3084	autophagy	abstract[156]|abstract|event[158]	new[156]|new|giv[158]	coref	20-4
19-10	3085-3092	process	abstract[156]|event[158]	new[156]|giv[158]	_	_
19-11	3093-3095	in	abstract[156]	new[156]	_	_
19-12	3096-3099	the	abstract[156]|abstract[159]	new[156]|giv[159]	_	_
19-13	3100-3110	regulation	abstract[156]|abstract[159]	new[156]|giv[159]	_	_
19-14	3111-3113	of	abstract[156]|abstract[159]	new[156]|giv[159]	_	_
19-15	3114-3117	the	abstract[156]|abstract[159]|place[161]	new[156]|giv[159]|giv[161]	coref	24-14[207_161]
19-16	3118-3125	ovarian	abstract[156]|abstract[159]|person|place[161]	new[156]|giv[159]|giv|giv[161]	_	_
19-17	3126-3133	reserve	abstract[156]|abstract[159]|place[161]	new[156]|giv[159]|giv[161]	_	_
19-18	3134-3136	of	abstract[156]|abstract[159]|place[161]	new[156]|giv[159]|giv[161]	_	_
19-19	3137-3147	primordial	abstract[156]|abstract[159]|place[161]|object[162]	new[156]|giv[159]|giv[161]|giv[162]	coref	20-35[173_162]
19-20	3148-3157	follicles	abstract[156]|abstract[159]|place[161]|object[162]	new[156]|giv[159]|giv[161]|giv[162]	_	_
19-21	3158-3159	.	_	_	_	_

#Text=For example , autophagy is implicated in maintaining the primordial oocyte pool in murine newborns , and the induction of autophagy at birth seems to be a crucial step to preserve the stock of primordial follicles .
20-1	3160-3163	For	_	_	_	_
20-2	3164-3171	example	_	_	_	_
20-3	3172-3173	,	_	_	_	_
20-4	3174-3183	autophagy	abstract	giv	coref	20-21
20-5	3184-3186	is	_	_	_	_
20-6	3187-3197	implicated	_	_	_	_
20-7	3198-3200	in	_	_	_	_
20-8	3201-3212	maintaining	_	_	_	_
20-9	3213-3216	the	place[165]	giv[165]	_	_
20-10	3217-3227	primordial	place[165]	giv[165]	_	_
20-11	3228-3234	oocyte	object|place[165]	giv|giv[165]	_	_
20-12	3235-3239	pool	place[165]	giv[165]	_	_
20-13	3240-3242	in	place[165]	giv[165]	_	_
20-14	3243-3249	murine	place[165]|abstract|person[167]	giv[165]|new|new[167]	_	_
20-15	3250-3258	newborns	place[165]|person[167]	giv[165]|new[167]	_	_
20-16	3259-3260	,	_	_	_	_
20-17	3261-3264	and	_	_	_	_
20-18	3265-3268	the	event[168]	new[168]	_	_
20-19	3269-3278	induction	event[168]	new[168]	_	_
20-20	3279-3281	of	event[168]	new[168]	_	_
20-21	3282-3291	autophagy	event[168]|abstract	new[168]|giv	_	_
20-22	3292-3294	at	event[168]	new[168]	_	_
20-23	3295-3300	birth	event[168]|event	new[168]|new	_	_
20-24	3301-3306	seems	_	_	_	_
20-25	3307-3309	to	_	_	_	_
20-26	3310-3312	be	_	_	_	_
20-27	3313-3314	a	event[171]	new[171]	_	_
20-28	3315-3322	crucial	event[171]	new[171]	_	_
20-29	3323-3327	step	event[171]	new[171]	_	_
20-30	3328-3330	to	_	_	_	_
20-31	3331-3339	preserve	_	_	_	_
20-32	3340-3343	the	object[172]	new[172]	_	_
20-33	3344-3349	stock	object[172]	new[172]	_	_
20-34	3350-3352	of	object[172]	new[172]	_	_
20-35	3353-3363	primordial	object[172]|object[173]	new[172]|giv[173]	_	_
20-36	3364-3373	follicles	object[172]|object[173]	new[172]|giv[173]	_	_
20-37	3374-3375	.	_	_	_	_

#Text=In the same manner , primordial follicle survival or apoptosis results from a balance between the expression of survival ( antiapoptotic ) and proapoptotic factors .
21-1	3376-3378	In	_	_	_	_
21-2	3379-3382	the	abstract[174]|event[176]|event[177]	giv[174]|giv[176]|giv[177]	coref|coref|coref	21-19[0_176]|21-19[0_176]|21-19[0_176]
21-3	3383-3387	same	abstract[174]|event[176]|event[177]	giv[174]|giv[176]|giv[177]	_	_
21-4	3388-3394	manner	abstract[174]|event[176]|event[177]	giv[174]|giv[176]|giv[177]	_	_
21-5	3395-3396	,	event[176]|event[177]	giv[176]|giv[177]	_	_
21-6	3397-3407	primordial	event[176]|event[177]	giv[176]|giv[177]	_	_
21-7	3408-3416	follicle	animal|event[176]|event[177]	giv|giv[176]|giv[177]	_	_
21-8	3417-3425	survival	event[176]|event[177]	giv[176]|giv[177]	_	_
21-9	3426-3428	or	event[177]	giv[177]	_	_
21-10	3429-3438	apoptosis	event[177]|event|abstract[179]	giv[177]|new|new[179]	_	_
21-11	3439-3446	results	event[177]|abstract[179]	giv[177]|new[179]	_	_
21-12	3447-3451	from	event[177]|abstract[179]	giv[177]|new[179]	_	_
21-13	3452-3453	a	event[177]|abstract[179]|abstract[180]	giv[177]|new[179]|giv[180]	_	_
21-14	3454-3461	balance	event[177]|abstract[179]|abstract[180]	giv[177]|new[179]|giv[180]	_	_
21-15	3462-3469	between	event[177]|abstract[179]|abstract[180]	giv[177]|new[179]|giv[180]	_	_
21-16	3470-3473	the	event[177]|abstract[179]|abstract[180]|abstract[181]	giv[177]|new[179]|giv[180]|new[181]	_	_
21-17	3474-3484	expression	event[177]|abstract[179]|abstract[180]|abstract[181]	giv[177]|new[179]|giv[180]|new[181]	_	_
21-18	3485-3487	of	event[177]|abstract[179]|abstract[180]|abstract[181]	giv[177]|new[179]|giv[180]|new[181]	_	_
21-19	3488-3496	survival	event[177]|abstract[179]|abstract[180]|abstract[181]|event	giv[177]|new[179]|giv[180]|new[181]|giv	_	_
21-20	3497-3498	(	_	_	_	_
21-21	3499-3512	antiapoptotic	substance	new	_	_
21-22	3513-3514	)	_	_	_	_
21-23	3515-3518	and	_	_	_	_
21-24	3519-3531	proapoptotic	abstract[184]	giv[184]	coref	22-2[185_184]
21-25	3532-3539	factors	abstract[184]	giv[184]	_	_
21-26	3540-3541	.	_	_	_	_

#Text=Among these factors , the proteins B-cell lymphoma 2 ( Bcl-2 ) and Bcl-2-associated X protein ( BAX ) likely play a critical role .
22-1	3542-3547	Among	_	_	_	_
22-2	3548-3553	these	abstract[185]	giv[185]	_	_
22-3	3554-3561	factors	abstract[185]	giv[185]	_	_
22-4	3562-3563	,	_	_	_	_
22-5	3564-3567	the	substance[186]|abstract[187]	new[186]|new[187]	_	_
22-6	3568-3576	proteins	substance[186]|abstract[187]	new[186]|new[187]	_	_
22-7	3577-3583	B-cell	substance[186]|abstract[187]	new[186]|new[187]	_	_
22-8	3584-3592	lymphoma	substance[186]|abstract[187]|abstract	new[186]|new[187]|new	_	_
22-9	3593-3594	2	substance[186]|abstract[187]	new[186]|new[187]	_	_
22-10	3595-3596	(	substance[186]|abstract[187]	new[186]|new[187]	_	_
22-11	3597-3602	Bcl-2	substance[186]|abstract[187]|time	new[186]|new[187]|new	_	_
22-12	3603-3604	)	substance[186]|abstract[187]	new[186]|new[187]	_	_
22-13	3605-3608	and	abstract[187]	new[187]	_	_
22-14	3609-3625	Bcl-2-associated	abstract[187]|substance[190]	new[187]|giv[190]	_	_
22-15	3626-3627	X	abstract[187]|substance[190]	new[187]|giv[190]	_	_
22-16	3628-3635	protein	abstract[187]|substance[190]	new[187]|giv[190]	_	_
22-17	3636-3637	(	_	_	_	_
22-18	3638-3641	BAX	object	new	_	_
22-19	3642-3643	)	_	_	_	_
22-20	3644-3650	likely	_	_	_	_
22-21	3651-3655	play	_	_	_	_
22-22	3656-3657	a	abstract[192]	giv[192]	_	_
22-23	3658-3666	critical	abstract[192]	giv[192]	_	_
22-24	3667-3671	role	abstract[192]	giv[192]	_	_
22-25	3672-3673	.	_	_	_	_

#Text=Thus , a synergistic and coordinated suppression of follicular activation , provided by multiple inhibitory and activator molecules , is necessary to preserve the primordial follicular stockpile in association with the process maintaining dormancy .
23-1	3674-3678	Thus	_	_	_	_
23-2	3679-3680	,	_	_	_	_
23-3	3681-3682	a	abstract[193]	new[193]	_	_
23-4	3683-3694	synergistic	abstract[193]	new[193]	_	_
23-5	3695-3698	and	abstract[193]	new[193]	_	_
23-6	3699-3710	coordinated	abstract[193]	new[193]	_	_
23-7	3711-3722	suppression	abstract[193]	new[193]	_	_
23-8	3723-3725	of	abstract[193]	new[193]	_	_
23-9	3726-3736	follicular	abstract[193]|event[194]	new[193]|giv[194]	_	_
23-10	3737-3747	activation	abstract[193]|event[194]	new[193]|giv[194]	_	_
23-11	3748-3749	,	_	_	_	_
23-12	3750-3758	provided	_	_	_	_
23-13	3759-3761	by	_	_	_	_
23-14	3762-3770	multiple	abstract[195]|abstract[196]	giv[195]|giv[196]	_	_
23-15	3771-3781	inhibitory	abstract[195]|abstract[196]	giv[195]|giv[196]	_	_
23-16	3782-3785	and	abstract[196]	giv[196]	_	_
23-17	3786-3795	activator	abstract[196]|substance[197]	giv[196]|giv[197]	_	_
23-18	3796-3805	molecules	abstract[196]|substance[197]	giv[196]|giv[197]	_	_
23-19	3806-3807	,	_	_	_	_
23-20	3808-3810	is	_	_	_	_
23-21	3811-3820	necessary	_	_	_	_
23-22	3821-3823	to	_	_	_	_
23-23	3824-3832	preserve	_	_	_	_
23-24	3833-3836	the	object[199]	new[199]	_	_
23-25	3837-3847	primordial	object[199]	new[199]	_	_
23-26	3848-3858	follicular	abstract|object[199]	giv|new[199]	coref	24-15
23-27	3859-3868	stockpile	object[199]	new[199]	_	_
23-28	3869-3871	in	_	_	_	_
23-29	3872-3883	association	abstract[200]	new[200]	_	_
23-30	3884-3888	with	abstract[200]	new[200]	_	_
23-31	3889-3892	the	abstract[200]|event[201]	new[200]|giv[201]	_	_
23-32	3893-3900	process	abstract[200]|event[201]	new[200]|giv[201]	_	_
23-33	3901-3912	maintaining	_	_	_	_
23-34	3913-3921	dormancy	event	new	_	_
23-35	3922-3923	.	_	_	_	_

#Text=Any disorder in these complex mechanisms can lead to a premature loss of the follicular reserve .
24-1	3924-3927	Any	abstract[203]	new[203]	_	_
24-2	3928-3936	disorder	abstract[203]	new[203]	_	_
24-3	3937-3939	in	abstract[203]	new[203]	_	_
24-4	3940-3945	these	abstract[203]|abstract[204]	new[203]|giv[204]	_	_
24-5	3946-3953	complex	abstract[203]|abstract[204]	new[203]|giv[204]	_	_
24-6	3954-3964	mechanisms	abstract[203]|abstract[204]	new[203]|giv[204]	_	_
24-7	3965-3968	can	_	_	_	_
24-8	3969-3973	lead	_	_	_	_
24-9	3974-3976	to	_	_	_	_
24-10	3977-3978	a	event[205]	new[205]	_	_
24-11	3979-3988	premature	event[205]	new[205]	_	_
24-12	3989-3993	loss	event[205]	new[205]	_	_
24-13	3994-3996	of	event[205]	new[205]	_	_
24-14	3997-4000	the	event[205]|place[207]	new[205]|giv[207]	_	_
24-15	4001-4011	follicular	event[205]|abstract|place[207]	new[205]|giv|giv[207]	_	_
24-16	4012-4019	reserve	event[205]|place[207]	new[205]|giv[207]	_	_
24-17	4020-4021	.	_	_	_	_
